Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 962 of 1,261
  1. US 7960372

    Bivalent Smac mimetics and the uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  2. US 7959925

    Trimeric OX40-immunoglobulin fusion protein and methods of use

    Providence Health System · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  3. US 7960133

    Methods of diagnosing leiomyoma by measuring catechol-O-methyltransferase

    The Board of Regents of the University of Texas System · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  4. US 7959929

    Materials and methods for respiratory disease control in canines

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  5. US 7959934

    Method for rapid generation of mature dendritic cells

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  6. US 7960535

    Recombinant lipidated PsaA protein, methods of preparation and use

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  7. US 7960369

    Receptor function regulator

    Takeda Pharmaceutical Company Limited · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  8. CA 2724937

    MEDICAMENT POUR LE TRAITEMENT DES ULCERES GASTRO-INTESTINAUX

    BIOCODEX [FR] · Granted Jun 8, 2011 · Expires Jun 3, 2031

    granted
  9. US 7956054

    Dual-acting pyrazole antihypertensive agents

    Theravance, Inc. · Granted Jun 7, 2011 · Expires Jun 2, 2031

    granted
  10. US 7955596

    B. anthracis prevention and treatment: mutant B. anthracis lacking luxs activity and furanone inhibition of growth, AI-2 quorum sensing, and toxin production

    UNIVERSITY OF CONNECTICUT · Granted Jun 7, 2011 · Expires Jun 2, 2031

    granted
  11. US 7956220

    MAO-B inhibitors useful for treating obesity

    Jenrin Discovery, LLC · Granted Jun 7, 2011 · Expires Jun 2, 2031

    granted
  12. US 7956086

    Methods for the formulation and manufacture of artesunic acid for injection

    The United States of America as represented by the Secretary of the Army · Granted Jun 7, 2011 · Expires Jun 2, 2031

    granted
  13. US 7956052

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jun 7, 2011 · Expires Jun 2, 2031

    granted
  14. US 7955602

    Annexin proteins and autoantibodies as serum markers for cancer

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 7, 2011 · Expires Jun 2, 2031

    granted
  15. US 7956028

    Protein stabilization formulations

    JOHNSON & JOHNSON REGENERATIVE THERAPEUTICS, LLC · Granted Jun 7, 2011 · Expires Jun 2, 2031

    granted
  16. US 7956177

    dsRNA compositions and methods for treating HPV infection

    Alnylam Pharmaceuticals, Inc. · Granted Jun 7, 2011 · Expires Jun 2, 2031

    granted
  17. CA 2724303

    COMBINAISON SYNERGIQUE DE COMPOSES ANALGESIQUES

    BIOCODEX [FR] · Granted Jun 3, 2011 · Expires May 29, 2031

    granted
  18. US 7951831

    Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors

    The Regents of the University of California · Granted May 31, 2011 · Expires May 26, 2031

    granted
  19. US 7951548

    IL-13 production inhibitor

    Takeda Pharmaceutical Company Limited · Granted May 31, 2011 · Expires May 26, 2031

    granted
  20. US 7951820

    Triazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 31, 2011 · Expires May 26, 2031

    granted
  21. US 7951845

    Composition and method of treating hearing loss

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 31, 2011 · Expires May 26, 2031

    granted
  22. US 7951817

    Pyridomorphinans, pyridazinomorphinans and use thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted May 31, 2011 · Expires May 26, 2031

    granted
  23. US 7951809

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted May 31, 2011 · Expires May 26, 2031

    granted
  24. US 7951909

    Immunogenic peptide composition comprising a promiscuous helper T cell epitope and an N-terminal fragment of Aβ1-42 peptide

    United Biomedical, Inc. · Granted May 31, 2011 · Expires May 26, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.